Case Number 6631
Request Date 25/03/2019
Completion Date 18/04/2019

 

Details of the Request

Within your health trust how many patients have you treated in the year 2018, regardless of reason;

  • Ambisome
  • Caspofungin (cancidas)
  • Cresemba
  • Noxafil / posaconazole
  • Voriconazole / VFEND
  • Zavicefta
  • Zerbaxa

 

If your trust is able to split by indication, please provide the following;

Within your health trust how many patients have you treated in the year 2018 for IA (invasive aspergillosis) with the following;

  • Cresemba
  • Ambisome (amphotericin B/amphotericin liposomal)
  • Voriconazole / VFEND
  • Caspofungin (cancidas)
  • Noxafil / posaconazole

 

Within your health trust how many patients have you treated in the year 2018 for cIAI (complicated intra-abdominal) with the following;

  • Ceftazidime-avibactam (Zavicefta)
  • Meropenem
  • Ceftolozane‒Tazobactam (Zerbaxa)

 

Within your health trust how many patients have you treated in the year 2018 for cUTI (complex urinary tract infection) with the following;

  • Ceftazidime-avibactam (Zavicefta)
  • Meropenem
  • Ceftolozane‒Tazobactam (Zerbaxa)

 

Within your health trust how many patients have you treated in the year 2018 for HAP/VAP (hospital acquired pneumonias and ventilated associated pneumonia) with the following;

  • Ceftazidime-avibactam (Zavicefta)
  • Meropenem
  • Ceftolozane‒Tazobactam (Zerbaxa)

 

Details of the Response

Within your health trust how many patients have you treated in the year 2018, regardless of reason;

Ambisome 18
Caspofungin (cancidas) 21
Cresemba 0
Noxafil/posaconazole 23
Voriconazole/VFEND 14
Zavicefta 0
Zerbaxa 0

 

Within your health trust how many patients have you treated in the year 2018 for IA (invasive aspergillosis) with the following;

Cresemba 0
Ambisome (amphotericin B/amphotericin liposomal) 0
Voriconazole/VFEND 0
Caspofungin (cancidas) 1
Noxafil/posaconazole 0

 

Within your health trust how many patients have you treated in the year 2018 for cIAI (complicated intra-abdominal) with the following;

Ceftazidime-avibactam (Zavicefta) 0
Meropenem 1
Ceftolozane‒Tazobactam (Zerbaxa) 0

 

Within your health trust how many patients have you treated in the year 2018 for cUTI (complex urinary tract infection) with the following;

Ceftazidime-avibactam (Zavicefta) 0
Meropenem 18
Ceftolozane‒Tazobactam (Zerbaxa) 0

 

Within your health trust how many patients have you treated in the year 2018 for HAP/VAP (hospital acquired pneumonias and ventilated associated pneumonia) with the following;

Ceftazidime-avibactam (Zavicefta) 0
Meropenem 6
Ceftolozane‒Tazobactam (Zerbaxa) 0